PSI has been working in HIV prevention among most at-risk populations (MARPs) in China since 2003; however, over this period, a gap has grown between this work and ensuring that our program beneficiaries are referred to and receive correct treatment, care and support services – in a non-stigmatizing and discriminating manner – at Government of China institutions. In China, the Government controls this aspect of service delivery and the private sector is excluded from doing so. To bridge this gap, China is developing a MARP-friendly Clinical Health Network (CHN) to be launched in FY12 under the USAID-funded Behavior Change Communications for Infectious Disease Prevention (BCC ID) project.
The CHN is designed to:
- increase access to health services for MARPs (Access);
- increase the portfolio of prevention and HIV and TB screening services offered to MARPs (Scope of Services);
- increase the quality of care (Quality);
- reduce disparities in the provision of health care to MARPs when compared with the general population (Equity) and;
- ensure cost per MARP reached is controlled (Cost-effectiveness).
Four existing sites have been identified to be the first pilot members of the CHN in Kunming, Yunnan Province, China. Additional private clinics will be added to the CHN in Kunming during FY12 and it is hoped the CHN will be expanded to Guangxi Province by the end of FY12.
The CHN will provide HIV rapid testing, STI screening and symptomatic screening to identify TB suspects among MARPs. PSI and partner peer educators will be trained in basic WHO-approved screening algorithms for TB, and these peer educators will escort clients exhibiting any, or a combination of, cough for more than 2 weeks, fever, night sweats and/or weight loss to a CHN MARP-friendly provider. Once at the provider, the client will have the opportunity to further consult with the provider and receive HIV rapid testing as necessary, STI screening and clinical symptomatic screening for TB. TB suspects will then be escorted by the peer educator to a Government of China TB diagnostic and treatment center for bacteriological confirmation of active TB.
PSI will provide on-going quality assurance to all CHN providers through regular trainings, refresher trainings and supportive supervision visits. Client quality perceptions will be assessed through client exit/follow-up interviews, mystery client visits, and follow-up interviews with treatment defaulters (specifically for TB clients to understand why they did not complete treatment). PSI will also provide anti-stigma and anti-discrimination training to Government of China institutions. MIS data will be used to regularly monitor the screening, treatment and referral services provided by the CHN providers.
In September 2011, an important milestone was reached in the establishment of the CHN. An MOU was signed with the Kunming Municipal AIDS Bureau, which has secured their support for its establishment. Without this support, the CHN would go nowhere.
Despite the fact that providing HIV-related services through social franchising is nothing new for PSI, the CHN is a new and innovative intervention for China. Not quite social franchising, but a hybrid of it given the Chinese operating context and we hope, in a modest way, a channel for us to expand delivery of quality health services to MARPs in Yunnan and Guangxi.